A Serious Business is a content website that publishes plain-language articles on medications, diseases, supplements, and online pharmacy safety, offering medication comparisons and practical safety checklists aligned to official guidelines where stated.
Published Jun 25, 2026
(Separated into "validated by observation" vs. "site assertions")
Major review platforms for enterprise software (G2, TrustRadius, Gartner Peer Insights, Capterra) do not generally host listings for consumer content websites. A Serious Business does not appear to be listed as a reviewable product on these platforms, and no dedicated listings or user reviews were found on those services.
In the absence of traditional third-party reviews, the most informative observable indicators are:
Because this is a consumer information publisher rather than a B2B software product, the ICP corresponds to readership segments.
Get a comprehensive analysis of A Serious Business Inc including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →When institutional-grade trust is required (for example, hospital systems or formal patient education programs), prefer MedlinePlus, Mayo Clinic, NHS, or specialty-society resources that provide institutional governance and verifiable review processes.
For medication purchasing guidance tied to a specific jurisdiction, consult regulatory sources aligned to that jurisdiction (e.g., FDA consumer guidance in the US, MHRA/NHS guidance in the UK) rather than a general-interest content site.
If auditable clinical review is required (named reviewers, credentials, and change logs), this site does not currently present sufficient public evidence.
Corporate/contact inconsistency: conflicting US and UK postal addresses appear across legal pages.
Lack of publicly visible credential transparency: medical reviewers and reviewer credentials are not clearly listed in the main About content.
No public security/compliance attestations such as SOC 2 or ISO 27001.
Minimal third-party review footprint or press coverage, which limits external validation and makes assessment of quality and bias more difficult.
A Serious Business Inc operates A Serious Business (company website), a content website positioned as a pharmaceutical information hub publishing plain-language articles about:
The site presents itself as a reference for both consumers and clinicians and indicates an emphasis on content aligned with official guidelines and research where applicable.